MTX pathway gene variants, erythrocyte methotrexate polyglutamates, and treatment outcomes in rheumatoid arthritis
Rheumatoid arthritis (RA) exhibits significant inter-patient variability in response to and toxicity from methotrexate (MTX). The clinical utility of erythrocyte methotrexate polyglutamates (MTXPGs) and MTX-pathway pharmacogenetics remains uncertain. This study investigates the relationships betwee...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2026-01-01
|
| Col·lecció: | Biomolecules & Biomedicine |
| Matèries: | |
| Accés en línia: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/13544 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|